MedTrace Logo

Sustained Cord Circulation at Emergency Cesarean Section

NCT06540222 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2200

Last updated 2025-09-22

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate if sustained cord circulation during resuscitation improves outcomes for term neonates born by emergency Cesarean section. The main question it aims to answer is: Does sustained cord circulation reduce admission rates to neonatal care?

Researchers will compare resuscitation with an uncut umblical cord to standard resuscitation practices to see if it provides better outcomes.

Participants (term neonates born by emergency Cesarean section) will:

Receive resuscitation with either sustained cord circulation or standard care Be monitored for admission to neonatal care and other predefined health outcomes

Conditions

  • Asphyxia Neonatorum
  • Fetal Hypoxia

Interventions

PROCEDURE

Sustained cord (≥ 180 seconds) resuscitation

Resuscitation performed in near proximity to the mother with umbilical cord uncut

PROCEDURE

Routine (< 60 seconds) cord clamping

Resuscitation performed at a designated area after umbilical cord is cut

Sponsors & Collaborators

  • Region Stockholm

    collaborator OTHER_GOV

  • Region Skane

    lead OTHER

Principal Investigators

  • Ola Andersson, MD PhD · Region Skåne, Lund University

  • Jenny Svedenkrans, MD PhD · Karolinska University Hospital, Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
37 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-08
Primary Completion
2027-11-30
Completion
2031-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06540222 on ClinicalTrials.gov